Sequence of CATL1_HUMAN

cathepsin L

P07711

333

37564

398382

Gal S.,Gottesman M.M.

Isolation and sequence of a cDNA for human pro-(cathepsin L).

Biochem. J.

253

303-306

1988

398383

Joseph L.J.,Chang L.C.,Stamenkovich D.,Sukhatme V.P.

Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts.

J. Clin. Invest.

81

1621-1629

1988

398385

Bechtel S.,Rosenfelder H.,Duda A.,Schmidt C.P.,Ernst U.,Wellenreuther R.,Mehrle A.,Schuster C.,Bahr A.,Bloecker H.,Heubner D.,Hoerlein A.,Michel G.,Wedler H.,Koehrer K.,Ottenwaelder B.,Poustka A.,Wiemann S.,Schupp I.

The full-ORF clone resource of the German cDNA consortium.

BMC Genomics

8

399-399

2007

398386

Humphray S.J.,Oliver K.,Hunt A.R.,Plumb R.W.,Loveland J.E.,Howe K.L.,Andrews T.D.,Searle S.,Hunt S.E.,Scott C.E.,Jones M.C.,Ainscough R.,Almeida J.P.,Ambrose K.D.,Ashwell R.I.S.,Babbage A.K.,Babbage S.,Bagguley C.L.,Bailey J.,Banerjee R.,Barker D.J.,Barlow K.F.,Bates K.,Beasley H.,Beasley O.,Bird C.P.,Bray-Allen S.,Brown A.J.,Brown J.Y.,Burford D.,Burrill W.,Burton J.,Carder C.,Carter N.P.,Chapman J.C.,Chen Y.,Clarke G.,Clark S.Y.,Clee C.M.,Clegg S.,Collier R.E.,Corby N.,Crosier M.,Cummings A.T.,Davies J.,Dhami P.,Dunn M.,Dutta I.,Dyer L.W.,Earthrowl M.E.,Faulkner L.,Fleming C.J.,Frankish A.,Frankland J.A.,French L.,Fricker D.G.,Garner P.,Garnett J.,Ghori J.,Gilbert J.G.R.,Glison C.,Grafham D.V.,Gribble S.,Griffiths C.,Griffiths-Jones S.,Grocock R.,Guy J.,Hall R.E.,Hammond S.,Harley J.L.,Harrison E.S.I.,Hart E.A.,Heath P.D.,Henderson C.D.,Hopkins B.L.,Howard P.J.,Howden P.J.,Huckle E.,Johnson C.,Johnson D.,Joy A.A.,Kay M.,Keenan S.,Kershaw J.K.,Kimberley A.M.,King A.,Knights A.,Laird G.K.,Langford C.,Lawlor S.,Leongamornlert D.A.,Leversha M.,Lloyd C.,Lloyd D.M.,Lovell J.,Martin S.,Mashreghi-Mohammadi M.,Matthews L.,McLaren S.,McLay K.E.,McMurray A.,Milne S.,Nickerson T.,Nisbett J.,Nordsiek G.,Pearce A.V.,Peck A.I.,Porter K.M.,Pandian R.,Pelan S.,Phillimore B.,Povey S.,Ramsey Y.,Rand V.,Scharfe M.,Sehra H.K.,Shownkeen R.,Sims S.K.,Skuce C.D.,Smith M.,Steward C.A.,Swarbreck D.,Sycamore N.,Tester J.,Thorpe A.,Tracey A.,Tromans A.,Thomas D.W.,Wall M.,Wallis J.M.,West A.P.,Whitehead S.L.,Willey D.L.,Williams S.A.,Wilming L.,Wray P.W.,Young L.,Ashurst J.L.,Coulson A.,Blocker H.,Durbin R.M.,Sulston J.E.,Hubbard T.,Jackson M.J.,Bentley D.R.,Beck S.,Rogers J.,Dunham I.

DNA sequence and analysis of human chromosome 9.

Nature

429

369-374

2004

398387

The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).

Genome Res.

14

2121-2127

2004

398388

Ritonja A.,Popovic T.,Kotnik M.,Machleidt W.,Turk V.

Amino acid sequences of the human kidney cathepsins H and L.

FEBS Lett.

228

341-345

1988

398389

Joseph L.J.,Lapid S.,Sukhatme V.P.

The major ras induced protein in NIH3T3 cells is cathepsin L.

Nucleic Acids Res.

15

3186-3186

1987

398390

Mason R.W.,Walker J.E.,Northrop F.D.

The N-terminal amino acid sequences of the heavy and light chains of human cathepsin L. Relationship to a cDNA clone for a major cysteine proteinase from a mouse macrophage cell line.

Biochem. J.

240

373-377

1986

398391

Menard R.,Carmona E.,Takebe S.,Dufour E.,Plouffe C.,Mason P.,Mort J.S.

Autocatalytic processing of recombinant human procathepsin L. Contribution of both intermolecular and unimolecular events in the processing of procathepsin L in vitro.

J. Biol. Chem.

273

4478-4484

1998

398392

Felbor U.,Dreier L.,Bryant R.A.,Ploegh H.L.,Olsen B.R.,Mothes W.

Secreted cathepsin L generates endostatin from collagen XVIII.

EMBO J.

19

1187-1194

2000

398393

Zhang H.,Li X.-J.,Martin D.B.,Aebersold R.

Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry.

Nat. Biotechnol.

21

660-666

2003

398394

Goulet B.,Baruch A.,Moon N.S.,Poirier M.,Sansregret L.L.,Erickson A.,Bogyo M.,Nepveu A.

A cathepsin L isoform that is devoid of a signal peptide localizes to the nucleus in S phase and processes the CDP/Cux transcription factor.

Mol. Cell

14

207-219

2004

398395

Liu T.,Qian W.-J.,Gritsenko M.A.,Camp D.G. II,Monroe M.E.,Moore R.J.,Smith R.D.

Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.

J. Proteome Res.

4

2070-2080

2005

398396

Simmons G.,Gosalia D.N.,Rennekamp A.J.,Reeves J.D.,Diamond S.L.,Bates P.

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry.

Proc. Natl. Acad. Sci. U.S.A.

102

11876-11881

2005

398397

Huang I.C.,Bosch B.J.,Li F.,Li W.,Lee K.H.,Ghiran S.,Vasilieva N.,Dermody T.S.,Harrison S.C.,Dormitzer P.R.,Farzan M.,Rottier P.J.,Choe H.

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells.

J. Biol. Chem.

281

3198-3203

2006

398398

Bosch B.J.,Bartelink W.,Rottier P.J.

Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide.

J. Virol.

82

8887-8890

2008

398399

Chen R.,Jiang X.,Sun D.,Han G.,Wang F.,Ye M.,Wang L.,Zou H.

Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry.

J. Proteome Res.

8

651-661

2009

398400

Burkard T.R.,Planyavsky M.,Kaupe I.,Breitwieser F.P.,Buerckstuemmer T.,Bennett K.L.,Superti-Furga G.,Colinge J.

Initial characterization of the human central proteome.

BMC Syst. Biol.

5

17-17

2011

398401

Rosenow A.,Noben J.P.,Jocken J.,Kallendrusch S.,Fischer-Posovszky P.,Mariman E.C.,Renes J.

Resveratrol-induced changes of the human adipocyte secretion profile.

J. Proteome Res.

11

4733-4743

2012

398402

Bian Y.,Song C.,Cheng K.,Dong M.,Wang F.,Huang J.,Sun D.,Wang L.,Ye M.,Zou H.

An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.

J. Proteomics

96

253-262

2014

398403

Zhou N.,Pan T.,Zhang J.,Li Q.,Zhang X.,Bai C.,Huang F.,Peng T.,Zhang J.,Liu C.,Tao L.,Zhang H.

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

J. Biol. Chem.

291

9218-9232

2016

398404

van den Bogaard E.H.J.,van Geel M.,van Vlijmen-Willems I.M.J.J.,Jansen P.A.M.,Peppelman M.,van Erp P.E.J.,Atalay S.,Venselaar H.,Simon M.E.H.,Joosten M.,Schalkwijk J.,Zeeuwen P.L.J.M.

Deficiency of the human cysteine protease inhibitor cystatin M/E causes hypotrichosis and dry skin.

Genet. Med.

21

1559-1567

2019

398405

Hoffmann M.,Kleine-Weber H.,Schroeder S.,Krueger N.,Herrler T.,Erichsen S.,Schiergens T.S.,Herrler G.,Wu N.H.,Nitsche A.,Mueller M.A.,Drosten C.,Poehlmann S.

SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.

Cell

181

1-10

2020

398406

Smieszek S.P.,Przychodzen B.P.,Polymeropoulos M.H.

Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.

Int. J. Antimicrob. Agents

55

106004-106004

2020

398407

Ou X.,Liu Y.,Lei X.,Li P.,Mi D.,Ren L.,Guo L.,Guo R.,Chen T.,Hu J.,Xiang Z.,Mu Z.,Chen X.,Chen J.,Hu K.,Jin Q.,Wang J.,Qian Z.

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.

Nat. Commun.

11

1620-1620

2020

398408

Bruchez A.,Sha K.,Johnson J.,Chen L.,Stefani C.,McConnell H.,Gaucherand L.,Prins R.,Matreyek K.A.,Hume A.J.,Muehlberger E.,Schmidt E.V.,Olinger G.G.,Stuart L.M.,Lacy-Hulbert A.

MHC class II transactivator CIITA induces cell resistance to Ebola virus and SARS-like coronaviruses.

Science

370

241-247

2020

398409

Koch J.,Uckeley Z.M.,Doldan P.,Stanifer M.,Boulant S.,Lozach P.Y.

TMPRSS2 expression dictates the entry route used by SARS-CoV-2 to infect host cells.

EMBO J.

40

1-20

2021

398410

Coulombe R.,Grochulski P.,Sivaraman J.,Menard R.,Mort J.S.,Cygler M.

Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment.

EMBO J.

15

5492-5503

1996

398411

Fujishima A.,Imai Y.,Nomura T.,Fujisawa Y.,Yamamoto Y.,Sugarawa T.

The crystal structure of human cathepsin L complexed with E-64.

FEBS Lett.

407

47-50

1997